Livingston 2007.

Trial name or title	NCT 00423878
Methods	Allocation: random. Blindness: single blind. Duration: 6 months. Design: parallel. Location: unclear.
Participants	Diagnosis: schizophrenia. Age: 16‐65 years. Gender: male/female participants. History: duration of illness not reported. Setting: not reported.
Interventions	1. Aripiprazole. 2. Risperidone. 3. Quetiapine. 4. Olanzapine.
Outcomes	Metabolic effects, adverse events, clinical efficacy and tolerability.
Starting date	January 2007.
Contact information
Notes